- Home
- ARWR vs STNG Comparison
ARWR vs STNG Comparison
Compare ARWR & STNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | STNG |
|---|---|---|
| Founded | 2003 | 2009 |
| Country | United States | Monaco |
| Employees | N/A | 24 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 4.0B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | STNG |
|---|---|---|
| Price | $84.36 | $74.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $83.40 | $83.33 |
| AVG Volume (30 Days) | ★ 1.8M | 870.4K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.22% |
| EPS Growth | ★ 99.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,142,321.00 | N/A |
| Revenue This Year | N/A | $4.31 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.06 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.30 | $41.50 |
| 52 Week High | $87.83 | $87.39 |
Technical Indicators
Market Signals| Indicator | ARWR | STNG |
|---|---|---|
| Relative Strength Index (RSI) | 63.71 | 43.95 |
| Support Level | $70.05 | $72.53 |
| Resistance Level | N/A | $82.58 |
| Average True Range (ATR) | 4.07 | 2.79 |
| MACD | 0.59 | -0.40 |
| Stochastic Oscillator | 79.10 | 36.25 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.